Ann: Appendix 4C - quarterly, page-3

Sales receipts for the September quarter suggest that the rate of deliveries for Labcon slowedin the Sept quarter. Was this planned and what rate should we expect in the coming quarters?

MD:  This certainly was planned. Towards the end of the calendar year and especially into calendar2019 there will be a substantial ramp in volumes to meet the FY19 $US1.1m commitment fromLabcon.

Labcon is putting in place the processes for scaled manufacture and progressing registrationof the Bluechiip enabled range. We at Bluechiip are also in the process of registering and scalingthe reader and software range, with both the Multi Vial Reader and Handheld readers movinginto production at Planet Innovation.

As per my past posts, sales in September quarter would be affected due to contract negotiations and rescheduling of volumes and ramp up planning. No surprise there and sales from Labcon only in FY19 to be around A$1.5m ish.. as suggested previously.